TRxADE HEALTH, Inc. (MEDS)

NASDAQ: MEDS · IEX Real-Time Price · USD
0.430
+0.056 (14.94%)
At close: Mar 24, 2023, 4:00 PM
0.428
-0.002 (-0.56%)
After-hours: Mar 24, 2023, 7:59 PM EDT
14.94%
Market Cap 4.01M
Revenue (ttm) 11.31M
Net Income (ttm) -3.33M
Shares Out 9.32M
EPS (ttm) -0.40
PE Ratio n/a
Forward PE 21.83
Dividend n/a
Ex-Dividend Date n/a
Volume 686,214
Open 0.370
Previous Close 0.374
Day's Range 0.370 - 0.449
52-Week Range 0.271 - 3.470
Beta 1.06
Analysts Buy
Price Target 2.30 (+434.88%)
Earnings Date May 8, 2023

About MEDS

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TR... [Read more]

Sector Healthcare
IPO Date Feb 13, 2020
Employees 47
Stock Exchange NASDAQ
Ticker Symbol MEDS
Full Company Profile

Financial Performance

In 2021, TRxADE HEALTH's revenue was $9.89 million, a decrease of -42.24% compared to the previous year's $17.12 million. Losses were -$5.32 million, 109.6% more than in 2020.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for MEDS stock is "Buy." The 12-month stock price forecast is $2.3, which is an increase of 434.88% from the latest price.

Price Target
$2.3
(434.88% upside)
Analyst Consensus: Buy
Stock Forecasts

News

TRxADE HEALTH, INC. to Report Q4 and Year-End 2022 Financial Results on Monday, March 27th at 5:30 p.m.

TAMPA, FL / ACCESSWIRE / March 13, 2023 / TRxADE HEALTH INC. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the ...

1 week ago - Accesswire

All You Need to Know About TRxADE (MEDS) Rating Upgrade to Strong Buy

TRxADE (MEDS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

2 months ago - Zacks Investment Research

Bonum Health(TM), LLC (a TRxADE HEALTH Company) Reaffirms its Commitment to Independent Pharmacies and Group Purchasing Organizations (GPOs) with its Novel Telemedicine Services Model

TAMPA, FL / ACCESSWIRE / December 6, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE" or the "Company") an integrated drug procurement, delivery, and healthcare platform, today announced that Bonum H...

3 months ago - Accesswire

TRxADE (MEDS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

TRxADE (MEDS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a tren...

4 months ago - Zacks Investment Research

All You Need to Know About TRxADE (MEDS) Rating Upgrade to Buy

TRxADE (MEDS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

4 months ago - Zacks Investment Research

7 Meme Stocks Smart Investors Shouldn't Touch With a 10-Foot Pole

Meme stocks represented one of the most remarkable developments in the equities space during much of the new normal. However, by 2022, this sector received a very rude awakening.

4 months ago - InvestorPlace

TRxADE (MEDS) Reports Q3 Loss, Lags Revenue Estimates

TRxADE (MEDS) delivered earnings and revenue surprises of 50% and 27.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

TRxADE HEALTH Reports Third Quarter Gross Margin of 58% and Q3 2022 Financial Results

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform

4 months ago - GlobeNewsWire

TRxADE HEALTH, INC. to Report Third Quarter 2022 Financial Results on Monday, November 7th at 5:00 p.m.

TAMPA, FL / ACCESSWIRE / October 24, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, th...

5 months ago - Accesswire

TRxADE Health Announces Pricing of $1.8 Million Registered Direct Offering

LUTZ, FL / ACCESSWIRE / October 4, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizi...

6 months ago - Accesswire

TRxADE HEALTH, INC. Taps Advisory Board Member and Leading Pharmaceutical Industry Expert, Mr.

TAMPA, FL, Oct. 03, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optim...

6 months ago - GlobeNewsWire

Wakefern Food Corp. and Bonum Health(TM), LLC (a TRxADE HEALTH Company) Ink a Telemedicine Services Deal

TAMPA, FL / ACCESSWIRE / September 20, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE" or the "Company") an integrated drug procurement, delivery, and healthcare platform, today announced that Bonum...

6 months ago - Accesswire

TRxADE HEALTH, Inc., Launches NEXT DAY Delivery Services Via TRxADE Prime Plus Program

TAMPA, FL, Aug. 30, 2022 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS)(“TRxADE” or the “Company”) an integrated drug procurement, delivery, and healthcare marketplace platform that connects b...

7 months ago - GlobeNewsWire

TRxADE HEALTH Announces Termination of Public Offering of Common Stock

LUTZ, FL / ACCESSWIRE / August 24, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizi...

7 months ago - Accesswire

TRxADE HEALTH Announces Proposed Public Offering of Common Stock

LUTZ, FL / ACCESSWIRE / August 23, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizi...

7 months ago - Accesswire

TRxADE HEALTH, INC. Appoints Leading Pharmaceutical Industry Expert Mr.

TAMPA, FL / ACCESSWIRE / August 16, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimiz...

7 months ago - Accesswire

TRxADE (MEDS) Reports Q2 Loss, Tops Revenue Estimates

TRxADE (MEDS) delivered earnings and revenue surprises of -44.44% and 13.07%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

TRxADE HEALTH Reports Second Quarter Revenue Growth of 73% and Q2 2022 Financial Results

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL / ACCESSWIRE / July 25, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE" or the "Company"), a health s...

8 months ago - Accesswire

Integra Pharma Solutions, LLC (d/b/a TRxADE Prime(TM) (a TRxADE HEALTH Company) Secures Preferred Distribution Agreement with GALT Pharmaceuticals, LLC

TAMPA, FL / ACCESSWIRE / July 12, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) ("TRxADE" or the "Company") an integrated drug procurement, delivery, and healthcare platform, today announced that Integra P...

9 months ago - Accesswire

TRxADE HEALTH, INC. to Report Second Quarter 2022 Financial Results on Monday, July 25th at 5:00 p.m.

TAMPA, FL / ACCESSWIRE / July 11, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the p...

9 months ago - Accesswire

Bonum Health(TM) (TRxADE HEALTH Company) Launches Veterinary Telemedicine Services

TAMPA, FL / ACCESSWIRE / May 19, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS) an integrated drug procurement, delivery, and healthcare platform, today announced that Bonum Health, a Digital Healthcare bus...

11 months ago - Accesswire

TRxADE (MEDS) Reports Q1 Loss, Tops Revenue Estimates

TRxADE (MEDS) delivered earnings and revenue surprises of -33.33% and 37.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

11 months ago - Zacks Investment Research

TRxADE HEALTH Reports First Quarter Revenue Growth of 6% and Q1 2022 Financial Results

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform TAMPA, FL / ACCESSWIRE / May 9, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE" or the "Company"), a health ser...

11 months ago - Accesswire

Earnings Preview: TRxADE (MEDS) Q1 Earnings Expected to Decline

TRxADE (MEDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

11 months ago - Zacks Investment Research

TRxADE HEALTH, INC. to Report First Quarter 2022 Financial Results on Monday, May 9th at 5:00 p.m.

TAMPA, FL / ACCESSWIRE / April 25, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the ...

11 months ago - Accesswire